Akoya Biosciences Inc. (AKYA)
NASDAQ: AKYA
· Real-Time Price · USD
1.25
-0.05 (-3.85%)
At close: May 23, 2025, 10:58 AM
Akoya Biosciences Revenue Breakdown
Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
---|---|---|---|---|
Product Revenue | 53.03M | 67.41M | 57.65M | 44.48M |
Product Revenue Growth | -21.34% | +16.93% | +29.62% | n/a |
Service and other Revenue | 28.64M | 29.22M | 17.21M | 10.44M |
Service and other Revenue Growth | -1.98% | +69.81% | +64.84% | n/a |
Consumables Revenue | 28.26M | 24.13M | 18.38M | 14.3M |
Consumables Revenue Growth | +17.09% | +31.31% | +28.54% | n/a |
Instruments Revenue | 23.83M | 42.09M | 38.63M | 28.69M |
Instruments Revenue Growth | -43.39% | +8.96% | +34.65% | n/a |
Service And Other Revenue | 17.28M | 18.93M | 636K | 1.49M |
Service And Other Revenue Growth | -8.73% | +2876.26% | -57.23% | n/a |
Standalone software products Revenue | 940K | 1.18M | n/a | n/a |
Standalone software products Revenue Growth | -20.41% | n/a | n/a | n/a |
Operating Expense Breakdown
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selling, General, and Administrative Revenue | 17.58M | 15.69M | 14.67M | 19.09M | 19.86M | 18.9M | 19.02M | 22.71M | 21.76M | 20.95M | 19.92M | 20.59M | 18.19M | 19.05M | 13.72M | 10.07M | 8.18M | 6.82M | 5.71M | 5.11M | 6.35M |
Selling, General, and Administrative Revenue Growth | +12.06% | +6.92% | -23.16% | -3.87% | +5.11% | -0.63% | -16.25% | +4.37% | +3.87% | +5.15% | -3.24% | +13.18% | -4.48% | +38.77% | +36.35% | +23.07% | +20.00% | +19.33% | +11.89% | -19.59% | n/a |
Research and Development Revenue | 5.56M | 4.43M | 4.47M | 5.29M | 5.55M | 4.67M | 5.17M | 6.27M | 5.77M | 6.43M | 5.47M | 5.6M | 5.71M | 5.56M | 4M | 2.95M | 3.19M | 2.53M | 2.28M | 2.42M | 2.37M |
Research and Development Revenue Growth | +25.47% | -1.01% | -15.39% | -4.79% | +18.93% | -9.72% | -17.54% | +8.66% | -10.26% | +17.69% | -2.36% | -2.03% | +2.71% | +39.11% | +35.70% | -7.68% | +26.07% | +11.10% | -5.83% | +2.02% | n/a |